Protein kinase c alpha location and the expression of phospho-MEK and MDR1 in hepatitis virus-related hepatocellular carcinoma biopsies

Chinese Journal of Physiology

Volumn 53, Issue 2, 2010, Pages 112-118

  Lin, Chien Chung ^a,b   Hwang, Jin Ming ^c   Tsai, Min Ting ^d   Su, Wei Wen ^d   Chen, Li Mien ^e   Lai, Tung Yuan ^f   Hsu, Hsi Hsien ^g   Yen, Shiow Kang ^a   Huang, Chih Yang ^f,h   Liu, Jer Yuh ^f,i  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b Armed Forces General Hospital   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

^h ASIA UNIVERSITY   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hepatitis c virus; Hepatocellular carcinoma; Mdr1; Phospho mek; Protein kinase c alpha

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHO MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; PROTEIN EXPRESSION;

EID: 77954877140     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2010.AMK028     Document Type: Article

References (43)

1. Alvaro, V., Touraine, P., Raisman, Vozari R., Bai-Grenier, F., Protein kinase C activity and expression in normal and adenomatous human pituitaries. Int. J. Cancer 50: 724-730, 1992.
2. Andrisani, O.M. and Barnabas, S. The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review). Int. J. Oncol. 15: 373-379, 1999.
3. Baeuerle, P.A. Pro-inflammatory signaling: last pieces in the NF-kB puzzle? Curr. Biol. 8: R19-R22, 1998.
4. Borowski, P., Schulze zur Wiesch, J., Resch, K., Feucht, H., Laufs, R. and Schmitz, H. Protein kinase C recognizes the protein kinase A-binding motif of nonstructural protein 3 of hepatitis C virus. J. Biol. Chem. 274: 30722-30728, 1999.
5. Budworth, J., Gant, T.W. and Gescher, A. Co-ordinate loss of protein kinase C and multidrug resistance gene expression in revertant MCF-7/Adr breast carcinoma cells. Br. J. Cancer 75: 1330-1335, 1997.
6. Chang, K.J., Lin, J.K., Lee, P.H., Hsieh, Y.S., Cheng, C.K. and Liu, J.Y. The altered activity of membrane-bound protein kinase C in human liver cancer. Cancer Lett. 105: 211-215, 1996.
7. Cheng, A.L., Chuang, S.E., Fine, R.L., Yeh, K.H., Liao, C.M., Lay, J.D. and Chen, D.S. Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochem. Pharmacol. 55: 523-531, 1998.
8. Chenivesse, X., Franco, D. and Brechot, C. MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis. J. Hepatol. 18: 168-172, 1993.
9. Choo, Q.L., Richman, K.H. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88: 2451-2455, 1991.
10. CLIP Group (Cancer of the Liver Italian Programme). Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. Lancet 352: 17-20, 1998.
11. Couldwell, W.T., Antel, J.P. and Yong, V.W. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery 31: 717-724, 1992.
12. Craxi, A., Pasqua, P., Giannuoli, G., Di Stefano, R., Simonetti, R.G. and Pagliaro, L. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis. Hepatogastroenterology 31: 55-59, 1984.
13. Cressman, D.E., Greenbaum, L.E., Haber, B.A. and Taub, R. Rapid activation of post-hepatectomy factor/nuclear factor kappa B in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269: 30429-30435, 1994.
14. Di Bisceglie, A.M. Hepatitis C. Lancet 351: 351-355, 1998.
15. Doong, S.L., Lin, M.H., Tsai, M.M., Li, T.R., Chuang, S.E. and Cheng, A.L. Transactivation of the human MDR1 gene by hepatitis B virus X gene product. J. Hepatol. 29: 872-878, 1998.
16. El-Serag, H.B. Hepatocellular carcinoma: an epidemiologic view. J. Clin. Gastroenterol. 35: S72-S78, 2002.
17. Farinati, F., De Maria, N., Marafin, C., Herszenyi, L., Del Prato, S., Rinaldi, M., Perini, L., Cardin, R. and Naccarato, R. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoem- bolization. Dig. Dis. Sci. 41: 2332-2339, 1996.
18. Ganem, D. and Varmus, H.E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56: 651-693, 1987.
19. Gill, P.K., Gescher, A. and Gant, T.W. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta. Eur. J. Biochem. 268: 4151-4157, 2001.
20. Han, Y., Han, Z.Y., Zhou, X.M., Shi, R., Zheng, Y., Shi, Y.Q. Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines. World J. Gastroenterol. 8: 441-445, 2002.
21. Hemmings, H.C., Jr. and Adamo, A.I. Effect of halothane on conventional protein kinase C translocation and down-regulation in rat cerebrocortical synaptosomes. Br. J. Anaesth. 78: 189-196, 1997.
22. Hsieh, Y.H., Wu, T.T., Huang, C.Y., Hsieh, Y.S., Hwang, J.M. and Liu, J.Y. p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepa-tocellular carcinoma cells. Cancer Res. 67: 4320-4327, 2007.
23. Hsu, S.L., Chou, Y.H., Yin, S.C. and Liu, J.Y. Differential effects of phorbol ester on growth and protein kinase C isoenzyme regulation in human hepatoma Hep3B cells. Biochem. J. 333: 57-64, 1998.
24. Kato, N., Yoshida, H., Ono-Nita, S.K., Kato, J., Goto, T., Otsuka, M., Lan, K., Matsushima, K., Shiratori, Y. and Omata, M. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer. Hepatology 32: 405-412, 2000.
25. Kekule, A.S., Lauer, U., Weiss, L., Luber, B. and Hofschneider, P.H. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361: 742-745, 1993.
26. Kopp, R., Noelke, B., Sauter, G., Schildberg, F.W., Paumgartner, G. and Pfeiffer, A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res. 51: 205-210, 1991.
27. Kusunoki, M., Sakanoue, Y., Hatada, T., Yanagi, H., Yamamura, T. and Utsunomiya, J. Protein kinase C activity in human colonic adenoma and colorectal carcinoma. Cancer 69: 24-30, 1992.
28. Lauer, U., Weiss, L., Lipp, M., Hofschneider, P.H. and Kekule, A.S. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology 19: 23-31, 1994.
29. Llovet, J.M. and Bruix, J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 37: 429-442, 2003.
30. Luber, B., Lauer, U., Weiss, L., Hohne, M., Hofschneider, P.H. and Kekule, A.S. The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. Res. Virol. 144: 311-321, 1993.
31. Musashi, M., Ota, S. and Shiroshita, N. The role of protein kinase C isoforms in cell proliferation and apoptosis. Int. J. Hematol. 72: 12-19, 2000.
32. Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334: 661-665, 1988.
33. Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1984.
34. O'Brian, C., Vogel, V.G., Singletary, S.E. and Ward, N.E. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49: 3215-3217, 1989.
35. O'Brian, C.A., Liskamp, R.M., Solomon, D.H. and Weinstein, I.B. Inhibition of protein kinase C by tamoxifen. Cancer Res. 45: 2462-2465, 1985.
36. Osborn, M.T., Berry, A., Ruberu, M.S., Ning, B., Bell, L.M. and Chambers, T.C. Phorbol ester induced MDR1 expression in K562 cells occurs independently of mitogen-activated protein kinase signaling pathways. Oncogene 18: 5756-5764, 1999.
37. Slater, S.J., Cox, K.J., Lombardi, J.V., Ho, C., Kelly, M.B., Rubin, E. and Stubbs, C.D. Inhibition of protein kinase C by alcohols and anaesthetics. Nature 364: 82-84, 1993.
38. Su, Q., Schroder, C.H., Hofmann, W.J., Otto, G., Pichlmayr, R. and Bannasch, P. Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27: 1109-1120, 1998.
39. Tai, D.I., Tsai, S.L., Chen, Y.M., Chuang, Y.L., Peng, C.Y., Sheen, I.S., Yeh, C.T., Chang, K.S., Huang, S.N., Kuo, G.C. and Liaw, Y.F. Activation of nuclear factor KB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. Hepatology 31: 656-664, 2000.
40. Tsai, J.H., Hsieh, Y.S., Kuo, S.J., Chen, S.T., Yu, S.Y., Huang, C.Y., Chang, A.C., Wang, Y.W., Tsai, M.T. and Liu, J.Y. Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Lett. 161: 171-175, 2000.
41. Tsai, J.H., Tsai, M.T., Su, W.W., Chen, Y.L., Wu, T.T., Hsieh, Y.S., Huang, C.Y., Yeh, K.T. and Liu, J.Y. Expression of protein kinase C alpha in biopsies and surgical specimens of human hepatocellular carcinoma. Chinese J. Physiol. 48: 139-143, 2005.
42. Wu, T.T., Hsieh, Y.H., Hsieh, Y.S. and Liu, J.Y. Reduction of PKC a decreases cell proliferation, migration, and invasion of human malignant hepatocellular carcinoma. J. Cell. Biochem. 103: 9-20, 2008.
43. Ying, T.H., Tsai, J.H., Wu, T.T., Tsai, M.T., Su, W.W., Hsieh, Y.S., and Liu, J.Y. Immunochemical localization of protein kinase Ca in the biopsies of human hepatocellular carcinoma. Chinese J. Physiol. 51: 269-274, 2008.